Phase II study of topical niosomal urea gel - an adjuvant in the treatment of psoriasis

International Journal of Pharmaceutical Sciences Review and Research

Volumn 7, Issue 1, 2011, Pages 1-7

  Lakshmi, P K ^a   Bhaskaran, Shyamala ^b  

^a G Pulla Reddy College of Pharmacy   (India)

^b Agnihothri College of Pharmacy   (India)

Author keywords

Hript; Human volunteer study; Niosomal topical gel; Pasi score; Transmembrane method; Urea niosomes

Indexed keywords

CHITOSAN; NIOSOME; PLACEBO; UREA;

ADJUVANT THERAPY; ADULT; ARTICLE; CHEMICAL ANALYSIS; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; DRUG PENETRATION; DRUG RESPONSE; DRUG STABILITY; ERYTHEMA; FEMALE; HUMAN; LIPID LAYER HYDRATION; MALE; PARTICLE SIZE; PATCH TEST; PHASE 2 CLINICAL TRIAL; PSORIASIS; SKIN EXFOLIATION; SKIN IRRITATION; SKIN PERMEABILITY; SURFACE PROPERTY; SYNTHESIS; TOXICITY TESTING; TRANSMEMBRANE PH GRADIENT;

EID: 80052669689     PISSN: None     EISSN: 0976044X     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Van Hat DA et al. Encapsulation of Lidocaine base and hydrochloride into Non-ionic Surfactant vesicles (NSVs) and Diffusion through Human Stratum Corneum in Vitro, European Journal of Pharmaceutical Sciences, 1996;4:147-157.
2. Van Hal DA et al. Diffusion of Estradiol from Nonionic Surfactant Vesicles through Human Stratum Corneum in vitro, STP Pharma Sciences, 1996: 6(1): 72-78.
3. Dowton SM et al. Influence of Liposomal Composition on topical Delivery of Encapsulated Cyclosporin A, I An In vitro study using hairless mouse skin, STP Pharma Sciences, 1993;3(5):404-407.
4. Jayaraman CS et al. Topical delivery of erythromycin from various formulations: An in vivo hairless mouse study, Journal of Pharmaceutical Sciences, 1996; 85(10):1082-1084.
5. Niemac S., et al. Influence of non-ionic liposomal composition on topical delivery of Peptide drugs into the pilosebaceous units: An in vivo Study using Hamster ear model, Pharmaceutical research, 1995; 12(8):1184-1188.
6. Olin B (Ed): Facts and Comparisons. JB Lippincott Co, St Louis, MO, 1990.
7. Jesberger B. Therapy of the symptom 'dry skin'z. hauter, 1988; 53 (suppl.3),12-15.
8. Rabbwp, uses of urea in cosmetology, cosmet and toilet. 1990; 109:97-102.
9. Hagemann I, Proksch E. Topical treatment by urea reduces epidermal hyperproliferation and induces differentiation in psoriasis. Acta Derm Venereol 1996; 76:353-356.
10. Singla AK, Chawla. Chitosan: Some Pharmaceutical and biological aspects- an update MPharmaceutics Division, University Institute of Pharmaceutical Sciences, Punjab University, Chandigarh,India.J Pharm Pharmacol, 2002;53(8): 1047-67.
11. Ballie AJ, Florence AT, Hume L, Muirhead GT, Rogerson A. The preparation and properties of niosomes-non-ionic surfactant vesicles.J.Pharm. Pharmacol, 1985; 37:863-868.
12. Mayer LD, Hope MJ, Cullis PR. Trans membrane pH gradient uptake. Biochim. Biophys. Acta 1986; 1190: 99-107.
13. Mazda F, Özer AY, Ercan MT, Hýncal AA, Preparation, Characterization, in vitro and In Vivo Studies on Urea Liposomes and Niosomes, STP Pharma Sci., 1997; 7: 205-214
14. Jia-You Fang.; Song-Yih Yu.; Pao-Chu Wu.; Yaw-Bin Huang.; Yi-Hung Tsai.;In Vitro skin permeation of estradiol from various proniosome formulations. Int. J. Pharma. 2001; 215: 91-99.
15. Sankar V. et, al, Design and evaluation of Nifedipine Transdermal Patches, J pharm. Sci., 2003; 65 (5): 510-515.
16. Aliasgar Shahiwala., Ambikanandan Misra. Studies in topical application of niosomally entrapped Nimesulide. J.Pharm.Pharmaceut.Sci. (www.ualberta.ca/~csps), 2002; 5: 220-225.
17. Agarwal R, Katare OP, Preparation and in vitro evaluation of Miconazole nitrate-loaded topical liposomes, Pharm. Tech, 2002; 11:48-60.
18. Tardiff RG, Hubner RP, Graves CG. Harmonization of thresholds for primary skin irritation from results of human repeated insult patch tests and laboratory animal skin irritation tests, J Appl Toxicol. 2003; 23:279-81.
19. Lynda Sutton BS et al. A clinical study to determine the efficacy and safety of 1% Methotrexate/azone (MAZ) gel applied topically once daily in patients with psoriasis vulgaris. Int. J. Dermatol. 2001; 40: 464-467.
20. Parthasarathi G, Udupa N, Umadevi P, Pillai GK. Nisome encapsulated of vincristine sulfateimproved anticancer activity with reduced toxicity in mice. J.Drug Target. 1994; 2:173-183.
21. Ijeoma F Uchegbu, Suresh P Vyas. Non-ionic surfactant based (niosomes) in drug delivery. Int. J. Pharma, 1998; 172L: 33-70.
22. Yoshioka T. et al. Preparation and Properties of vesicles (niosomes) of sorbitan monoesters (Span 20, 40, 60 and 80) and sorbitan triester (Span 85), International Journal of Pharmaceutics, 1994;105:1-6.